Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

Defence Therapeutics is a Canadian Biotech company developing next generation bio-pharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.

O3 Mining is engaged in acquiring, exploring, and developing precious mineral deposits in Canada.

NGEx Minerals is actively seeking to add to its portfolio of projects as part of its overall growth strategy.